ARCHIVES

FDA, ASCO Meet to Review Drug Approval Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 17 | April 25, 2003

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

ACCC Planning Session Considers Community Impact

August 31, 1979

HPV DNA Testing Reduced Cervical Cancer Precursors

September 24, 2010

Low-Dose Tamoxifen May Be Effective In Treating Breast Cancer, Study Finds

April 25, 2003

Obituary: Lawrence Garfinkel, ACS Epidemiologist

January 22, 2010